| Product NDC: | 16714-311 | 
| Proprietary Name: | venlafaxine | 
| Non Proprietary Name: | venlafaxine | 
| Active Ingredient(s): | 25 mg/1 & nbsp; venlafaxine | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | TABLET | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 16714-311 | 
| Labeler Name: | NorthStar RxLLC | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | ANDA078932 | 
| Marketing Category: | ANDA | 
| Start Marketing Date: | 20101221 | 
| Package NDC: | 16714-311-03 | 
| Package Description: | 1000 TABLET in 1 BOTTLE (16714-311-03) | 
| NDC Code | 16714-311-03 | 
| Proprietary Name | venlafaxine | 
| Package Description | 1000 TABLET in 1 BOTTLE (16714-311-03) | 
| Product NDC | 16714-311 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | venlafaxine | 
| Dosage Form Name | TABLET | 
| Route Name | ORAL | 
| Start Marketing Date | 20101221 | 
| Marketing Category Name | ANDA | 
| Labeler Name | NorthStar RxLLC | 
| Substance Name | VENLAFAXINE HYDROCHLORIDE | 
| Strength Number | 25 | 
| Strength Unit | mg/1 | 
| Pharmaceutical Classes | Norepinephrine Uptake Inhibitors [MoA],Serotonin and Norepinephrine Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA] |